ROCKVILLE, Md.--(BUSINESS WIRE)--July 17, 2006--Celera Genomics (NYSE:CRA - News), an Applera Corporation business, today announced the publication of data from its research studies showing that variants in the death-associated protein kinase 1 (DAPK1) gene on human chromosome 9 correlate strongly with risk for late-onset Alzheimer’s disease. These research findings were presented today at the International Conference on Alzheimer’s Disease 2006 in Madrid, Spain, and will appear in the August 2006 edition of Human Molecular Genetics, currently available online at http://hmg.oxfordjournals.org/papbyrecent.dtl.
